Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients

Figure 3

Predictive value of the ARS. (a) The layout of increasing risk scores in the training set. (b) The clinical outcome of EC cases in the training set. (c) Kaplan–Meier curves of survival outcome between two groups in the training set. (d) ROC curves of predictive performance of the ARS in the training set. (e–h) Similar results confirmed the validation and entire sets.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)